Trademark: 97116019
Status Date
Monday, January 1, 2024
Filing Date
Tuesday, November 9, 2021
Published for Opposition
Tuesday, October 4, 2022
Abandoned Date
Monday, January 1, 2024
5 Novel drugs, namely, pharmaceutical preparations for treating neurogenerative diseases including ALS, Alzheimer's, and Parkinson's, and for treating dementia, stroke, traumatic brain injury, and cancer
Jan 2, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 1, 2024
Abandonment - No Use Statement Filed
Apr 6, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2023
Sou Extension 1 Granted
Apr 4, 2023
Sou Extension 1 Filed
Apr 4, 2023
Sou Teas Extension Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 26, 2022
Approved For Pub - Principal Register
Aug 19, 2022
Examiner's Amendment Entered
Aug 19, 2022
Notification Of Examiners Amendment E-Mailed
Aug 19, 2022
Examiners Amendment E-Mailed
Aug 19, 2022
Examiners Amendment -Written
Aug 19, 2022
Assigned To Examiner
Nov 17, 2021
New Application Office Supplied Data Entered
Nov 12, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
